Abnormal magnesium status in patients with cardiovascular diseases

Clinical Science

Volumn 98, Issue 2, 2000, Pages 175-181

  Sasaki, Shota ^a   Oshima, Tetsuya ^a   Matsuura, Hideo ^a   Ozono, Ryoji ^a   Higashi, Yukihito ^a   Sasaki, Nobuo ^a   Matsumoto, Toshiyuki ^a   Nakano, Yukiko ^a   Ueda, Atsushi ^a   Yoshimizu, Atsunori ^a   Kurisu, Satoshi ^a   Kambe, Masayuki ^a   Kajiyama, Goro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Arrhythmia; Cardiovascular disease; Diabetes mellitus; Hypertension; Magnesium

Indexed keywords

MAGNESIUM; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; ERYTHROCYTE; ESSENTIAL HYPERTENSION; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERCHOLESTEROLEMIA; ION SELECTIVE ELECTRODE; IONIZATION; ISCHEMIC HEART DISEASE; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MALE; PRIORITY JOURNAL;

EID: 0008765697     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0980175     Document Type: Article

References (39)

1. 1 Wacker, W. E. and Parisi, A. F. (1968) Magnesium metabolism. N. Engl. J. Med. 278, 772-776
2. 2 Reinhart, R. A. (1998) Magnesium metabolism. Arch. Intern. Med. 148, 2415-2420
3. 3 Sharrett, A. R. (1981) Water hardness and cardiovascular disease. Circulation 63, 247a-250a
4. 4 Stitt, F. W., Clayton, D. G., Crawford, M. D. and Morris, J. N. (1973) Clinical and biochemical indicators of cardiovascular disease among men living in hard and soft water areas. Lancet i, 122-126
5. 5 Whang, R. (1987) Magnesium deficiency: pathogenesis, prevalence, and clinical implications. Am. J. Med. 82, 24-29
6. 6 Dycker, T. and Wester, P. O. (1979) Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusion in patients on diuretic treatment. Am. Heart J. 97, 12-18
7. 7 Altura, B. M. and Altura, B. T. (1991) Cardiovascular risk factors and magnesium: relationships to atherosclerosis, ischmic heart disease and hypertension. Magnesium Trace Elem. 10, 182-192
8. 8 Resnick, L. M., Gupta, R. K. and Laragh, R. K. (1984) Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc. Natl. Acad. Sci. U.S.A. 81, 6511-6515
9. 9 Paolisso, G., Scheen, A., D'Onofrio, F. and Lefebvre, P. (1990) Magnesium and glucose homeostasis. Diabetologia 33, 511-514
10. 10 White, Jr., J. R. and Campbell, R. K. (1993) Magnesium and diabetes: a review. Ann. Pharmacother. 27, 775-780
11. 11 Zehender, M., Meinertz, T., Faber, T., Caspary, A., Jeron, A., Bremm, K. and Just, H. (1997) Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. J. Am. Coll. Cardiol. 29, 1028-1034
12. 12 Bernardi, D., Dini, F. L., Azzarelli, A., Giaconi, A., Volterrani, C. and Lunardi, M. (1995) Sudden cardiac death rate in an area characterized by high incidence of coronary artery disease and low hardness of drinking water. Angiology 46, 145-149
13. 13 Altura, B. T., Shirey, T. L., Young, C. C. et al. (1994) Characterization of a new ion selective electrode for ionized magnesium in whole blood, plasma, serum, and aqueous samples. Scand. J. Clin. Lab. Invest. Suppl. 217, 21-36
14. 14 Lewenstam, A. (1994) Design and pitfalls of ion selective electrodes. Scand. J. Clin. Lab. Invest. Suppl. 217, 11-19
15. 15 WHO Study Group (1985) Diabetes Mellitus. WHO Tech. Rep. Ser. 727, 10-14
16. 16 Legrand, C., Okitolonda, W., Pottier, A. M, Lederer, J. and Henquin, J. C. (1987) Glucose homeostasis in magnesium-deficient rats. Metab. Clin. Exp. 36, 160-164
17. 17 Paolisso, G., Scheen, A., Cozzolino, D. et al. (1994) Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J. Clin. Endocrinol. Metab. 78, 1510-1514
18. 18 Hatwal, A., Gujral, A. S., Bhatia, R. P., Agrawal, J. K. and Bajpai, H. S. (1989) Association of hypomagnesemia with diabetic retinopathy. Acta Ophthalmol. 67, 714-716
19. 19 Paolisso, G., Sgambato, S., Giugliano, D. et al. (1988) Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients. Diabctologia 31, 910-915
20. 20 Resnick, L. M., Barbagallo, M., Gupta, R. K. and Laragh, J. H. (1993) Ionic basis of hypertension in diabetes mellitus: role of hyperglycemia. Am. J. Hypertens. 6, 413-417
21. 21 Djurhuus, M. S., Skott, P., Hother, N. O., Klitgaard, N. A. and Beck, N. H. (1995) Insulin increases renal magnesium excretion: a possible cause of magnesium depletion in hyperinsulinaemic states. Diabetes Med. 12, 664-669
22. 22 Woods, K. L. (1991) Possible pharmacological actions of magnesium in acute myocardial infarction. Br. J. Clin. Pharmacol. 32, 3-10
23. 23 Iseri, L. T. (1990) Role of magnesium in cardiac tachyarrhythmias. Am. J. Cardiol. 65, 47k-50k
24. 24 Horner, S. M. (1992) Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality: meta-analysis of magnesium in acute myocardial infarction. Circulation 86, 774-779
25. 25 Woods, K. L., Fletcher, S., Roffe, C. and Haider, Y. (1992) Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339, 1553-1558
26. 26 ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group (1995) ISIS-4 : a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345, 669-685
27. 27 DiCarlo, L. A., Morady, F., Buitleir, M., Krol, R. B., Schurig, L. and Annesley, T. M. (1986) Effect of magnesium sulfate on cardiac conduction and refractoriness in humans. J. Am. Coll. Cardiol. 7, 1356-1362
28. 28 Lind, L., Lithell, H., Pollare, T. and Ljunghall, S. (1991) Blood pressure response during long-term treatment with magnesium is dependent on magnesium status: a double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. Am. J. Hypertens. 4, 674-679
29. 29 Motoyama, T., Sano, H. and Fukuzaki, H. (1989) Oral magnesium supplementation in patients with essential hypertension. Hypertension 13, 227-232
30. 30 Ferrara, L. A., Iannuzzi, R., Castaldo, A. et al. (1992) Long-term magnesium supplementation in essential hypertension. Cardiology 81, 25-33
31. 31 Albert, D. G., Morita, Y. and Iseri, L. T. (1958) Serum magnesium and plasma sodium levels in essential vascular hypertension. Circulation 17, 761-764
32. 32 Resnick, L. M., Laragh, J. H., Sealey, J. E. and Alderman, M. H. (1983) Divalent cations in essential hypertension: relationship between ionized calcium, magnesium, and plasma renin activity. N. Engl. J. Med. 309, 888-891
33. 33 Kjeldsen, S. E., Sejersted, O. M., Frederichsen, P., Leren, P. and Eide, I. K. (1990) Increased erythrocyte magnesium in never treated essential hypertension. Am. J. Hypertens. 3, 573-575
34. 31P nuclear magnetic resonance measurement of free erythrocyte magnesium concentration in man and its relation to blood pressure. Clin. Sci. 74, 513-517
35. 2+ in essential hypertension. Am. J. Physiol. 275, R574-R579
36. 2+ in genetically hypertensive rats. Hiroshima J. Med. Sci. 48, 1-8
37. 37 Oshima, T., Matsuura, H., Matsumoto, K., Kido, K. and Kajiyama, G. (1988) Role of cellular calcium inhibits salt sensitivity of patients with essential hypertension. Hypertension 11, 703-707
38. 38 Oshima, T., Young, E. W., Bukoski, R. D. and McCarron, D. A. (1990) Abnormal calcium handling by platelets of spontaneously hypertensive rats. Hypertension 15, 606-611
39. 2+ entry in vascular smooth muscle cells. Circulation 95, 2567-2572